RELAPSE/RECURRENCE
Clinical trials for RELAPSE/RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE/RECURRENCE trials appear
Sign up with your email to follow new studies for RELAPSE/RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial tests gentler chemo for Tough-to-Treat leukemia
Disease control Recruiting nowThis study compares two treatment approaches for adults whose acute myeloid leukemia has returned or not responded to initial therapy. Participants will receive either a milder, low-intensity therapy or a stronger, high-dose chemotherapy. The goal is to see if the gentler option …
Matched conditions: RELAPSE/RECURRENCE
Phase: PHASE3 • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
New antibody combo shows promise for hard-to-treat lymphoma
Disease control Recruiting nowThis study tests whether adding the experimental drug lacutamab to standard chemotherapy helps people with a rare type of blood cancer (peripheral T-cell lymphoma) that has returned or stopped responding to treatment. About 56 adults whose cancer cells have a specific marker call…
Matched conditions: RELAPSE/RECURRENCE
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New triple-drug attack shows promise for stubborn leukemia
Disease control Recruiting nowThis study tests a combination of three drugs (bugitinib, venetoclax, and cytarabine) in adults with acute myeloid leukemia that has come back or not responded to treatment. The goal is to see if the combo can wipe out hidden cancer cells and keep them away. About 10 participants…
Matched conditions: RELAPSE/RECURRENCE
Phase: PHASE2 • Sponsor: Shenzhen University General Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC